Natural T helper 17 (nT H 17) cells are a population of interleukin 17 (IL-17)-producing cells that acquire effector function in the thymus during development. Here we demonstrate that the serine/threonine kinase Akt has a critical role in regulating nT H 17 cell development. Although Akt and the downstream mTORC1-ARNT-HIFa axis were required for generation of inducible T H 17 (iT H 17) cells, nT H 17 cells developed independently of mTORC1. In contrast, mTORC2 and inhibition of Foxo proteins were critical for development of nT H 17 cells. Moreover, distinct isoforms of Akt controlled the generation of T H 17 cell subsets, as deletion of Akt2, but not of Akt1, led to defective generation of iT H 17 cells. These findings define mechanisms regulating nT H 17 cell development and reveal previously unknown roles of Akt and mTOR in shaping subsets of T cells.
IL-17 and cells that produce this cytokine are important in mediating protection against extracellular pathogens 1 . Dysregulation of IL-17 has also been linked to autoimmunity and inflammatory disorders; hence, there is great interest to better define cell types that produce IL-17 and to understand how its production is regulated. The best characterized source of IL-17 is T H 17 cells that arise from naive CD4 + T cells in response to antigen and cytokine stimulation in peripheral lymphoid organs, here referred to as iT H 17 cells. Recently, we and others have identified another IL-17 + CD4 + T cell population that acquires the capacity to produce IL-17 during development in the thymus 2, 3 . These nT H 17 cells are poised to produce cytokines upon stimulation without further differentiation in the peripheral tissues. Although iT H 17 cells and nT H 17 cells have many features in common, which include expression of the transcription factor RORγt, the activation and memory marker CD44 and the chemokine receptor CCR6, and production of IL-17A (commonly referred to as IL-17), IL-17F and IL-22, the signaling pathways directing the development of these cells are not well understood.
Akt is a serine/threonine kinase that has a central role in diverse processes including cell survival, proliferation, differentiation and metabolism. In T cells, Akt regulates development and is activated upon engagement of cytokine, co-stimulatory and antigen receptors 4 . These extracellular signals activate phosphoinositol-3-OH kinase (PI(3)K) to generate phophatidylinositol-3′-phosphate (PIP 3 ) to which Akt binds and thereby localizes to the plasma membrane, where it is phosphorylated at two key residues. Phosphoinositidedependent kinase 1 (PDK1) phosphorylates Akt at Thr308, whereas phosphorylation at Ser473 is mediated by the kinase mTORC2. Akt phosphorylates targets including the serine/threonine kinase GSK3, transcription factors Foxo1 and Foxo3a, and tuberous sclerosis complex 2 (TSC2), which leads to activation of the kinase mTORC1. mTORC1 and mTORC2 are two distinct complexes that have a common core catalytic subunit, mTOR 5 . mTORC1 consists of mTOR, Deptor, mLST8, PRAS40 and the scaffolding protein Raptor. Activation of mTORC1 promotes phosphorylation of downstream translational regulators, cell growth and metabolism 6 . mTORC2 also contains Deptor and mLST8 but, unlike mTORC1, includes Protor, mSIN1 and Rictor. Disruption of mTORC2 specifically abolishes phosphorylation of Akt at Ser473 but not at Thr308, resulting in the loss of phosphorylation of Foxo proteins 7, 8 . Of note, loss of mTORC2 does not abrogate phosphorylation of all Akt substrates, as GSK3 and TSC2 are still phosphorylated in its absence.
Both Akt and mTOR are essential for regulating the function and differentiation of CD4 + T cell subsets 9 . In vitro blockade of Akt signaling using inhibitors of Akt results in robust induction of Foxp3 (ref. 10) , a critical regulator of T regulatory (T reg ) cells, whereas expression of constitutively active Akt inhibits generation of T reg cells both in vitro from peripheral CD4 + T cells and in vivo among developing thymocytes 11 . Consistent with these findings, CD4 + T cells lacking mTOR do not differentiate into T H 
1, T H 2 or iT H 17 cells and instead become
Foxp3 + T reg cells 12 . Moreover, selective inhibition of mTORC1 results in defective T H 1 and iT H 17 cell differentiation but intact T H 2 cell differentiation, whereas in the absence of mTORC2 activity, CD4 + T cells do not differentiate into T H 2 cells but retain their ability to become iT H 17 cells 13, 14 . To date, however, neither the role of Akt or mTOR in the development of nT H 17 cells had been studied to our knowledge.
Using genetic and pharmacological modulation of Akt activity, we found that Akt is required for the development of both nT H 17 cells and iT H 17 cells. However, unlike iT H 17 cells, which require mTORC1 activity but not mTORC2 activity for their development, we found that nT H 17 cells develop normally in the absence of mTORC1 activity but rely on mTORC2. In line with the role of Akt and mTORC2 in nT H 17 cells, mice deficient in both Foxo1 and Foxo3a (proteins whose functions are blocked by activity of Akt and mTORC2) exhibited enhanced nT H 17 cell development compared to wild-type mice. In addition to distinct upstream activation, Akt isoform-specific activity also differently contributed to the development of nT H 17 cells and iT H 17 cells. Deletion of Akt2 resulted in defective iT H 17 cell differentiation but preservation of nT H 17 cell development. Collectively, our findings reveal critical roles of Akt isoforms and the two mTOR complexes in controlling the development of subsets of T H 17 cells.
RESULTS

Akt regulates the development of nT H 17 and iT H 17 cells
To investigate the signaling pathways required for development of nT H 17 cells, we examined phosphorylation of Akt in freshly isolated mouse nT H 17 cells, without the addition of extracellular stimuli and without serum in the medium. Flow cytometry analysis revealed constitutive phosphorylation of Ser473 in nT H 17 cells but not in thymic Foxp3 + natural T reg (nT reg ) cells or 'naive' (CD44 lo CCR6 − ) CD4 + CD8single-positive thymocytes (Fig. 1a) . In line with this finding, S6 kinase (S6K) and the protein S6 were also phosphorylated in nT H 17 cells but not in naive CD4 + CD8 − thymocytes ( Fig. 1b) , suggesting that Akt is constitutively activated in nT H 17 cells. We verified the detection of phosphorylated S6K and phosphorylated S6 by the diminished fluorescence detected by flow cytometry in rapamycintreated nT H 17 cells.
Although nT H 17 cells have been described in mice 2,3 , it has been unclear whether a similar population exists in humans. In 18-19-week-old human fetal thymic tissue, we readily observed IL-17 + CD4 + CD8 − TCRαβ + cells ( Fig. 1c ) that constituted 1-2% of the CD4 + CD8 − thymocyte population. Like their counterparts in the mouse, human nT H 17 cells expressed RORγt and CCR6 and did not coexpress Foxp3 ( Supplementary Fig. 1a,b) . nT H 17 cells were present in human umbilical cord blood, albeit at a lower frequency compared to the thymus (Supplementary Fig. 1c ). In human thymic nT H 17 cells, we observed constitutive phosphorylation of Akt on Ser473 (Fig. 1d) .
Given the constitutive phosphorylation of Akt in nT H 17 cells, we hypothesized that Akt may regulate development of these cells. To test this notion, we used pharmacological and genetic approaches to modulate Akt activity. First, we used an allosteric Akt inhibitor, AKTi, which targets both Akt1 and Akt2 isoforms, in fetal thymic organ culture to assess the effect of the loss of Akt function on development of nT H 17 cells. As Akt is critical for development of early thymocytes 15, 16 , we allowed fetal thymi to develop for 5 d before adding the inhibitor to ensure normal transition from the CD4 − CD8 − to the CD4 + CD8 + thymocyte stage. This strategy allowed us to interrogate the importance of Akt activity during the transition from the CD4 + CD8 + to the CD4 + CD8 − stage. Although treatment with AKTi affected overall thymic cellularity, primarily by lowering the number of CD4 + CD8 + cells, the development and frequency of CD4 + CD8 − thymocytes were similar in AKTi-treated and nontreated cultures ( Supplementary  Fig. 2 ). Inhibition of Akt resulted in a significantly smaller nT H 17 cell population compared to that in a control fetal thymic organ culture ( Fig. 1e) . This difference was not simply due to the inhibition of cytokine production, as the population of RORγt + CD44 hi cells was also smaller, suggesting that Akt controls development of nT H 17 cells at the transcriptional level ( Fig. 1e) . As expected given the known role of Akt as a negative regulator of Foxp3 expression 11 , fetal thymic organ cultures treated with AKTi had a greater percentage of Foxp3 + nT reg cells compared to nontreated cultures (Fig. 1e) . This effect was not specific to AKTi, as use of a pharmacologically distinct inhibitor of Akt (MK-2206) resulted in the same effect on nT H 17 and nT reg cells ( Supplementary Figs. 2 and 3a) .
To complement the Akt loss-of-function studies, we investigated the effect of enhanced Akt activity on development of nT H 17 cells. For these studies, we used transgenic mice expressing a myristoylated form of Akt (myr-Akt), which causes it to associate with the plasma membrane, resulting in constitutive activation 17 . Mice expressing myr-Akt exhibited greatly enhanced nT H 17 cell development compared to controls as assessed by measuring both cytokine production and RORγt expression ( Fig. 1f) . These data suggest that activated Akt drives more developing thymocytes to adopt an nT H 17 cell fate.
These findings led us to investigate whether Akt also has a role in the generation of iT H 17 cells. Akt regulates production of IL-17 in memory human T cells 18 , but the role of Akt in the development of iT H 17 cells from naive T cells has not been directly evaluated to our knowledge. We activated purified naive CD4 + splenic T cells for 18 h with anti-CD3 and anti-CD28 and then cultured them for 36 h in the presence of iT H 17 cell-promoting cytokines with or without AKTi. Treatment with AKTi inhibited differentiation of iT H 17 cells in a dose-dependent manner ( Fig. 1g) . A substantial population of iT reg cells was generated under iT H 17 cell-promoting conditions when AKTi was added, and this population increased in a dose-dependent manner, highlighting the reciprocal developmental relationship between iT H 17 and iT reg cells. We observed similar results with MK-2206 ( Supplementary  Fig. 3b ). Taken together, these results show that activation of Akt is critical for both nT H 17 and iT H 17 cell development.
nT H 17 cell development is independent of ARNT-HIFa-mTORC1 Akt phosphorylates several substrates, including TSC2, which leads to activation of mTORC1 ( Supplementary Fig. 4) . Among mTORC1 target genes, recent studies have identified hypoxia-inducible factor (HIF)1α as a key transcriptional regulator of iT H 17 cell development 19, 20 . Activity of HIF1α requires dimerization with aryl hydrocarbon receptor nuclear translocator (ARNT; also known as HIF1β) 21 . Under in vitro iT H 17 cell differentiation-promoting conditions, ARNT-deficient CD4 + T cells, from mice with loxP-flanked Arnt alleles that also expressed Cre recombinase from the hematopoieticspecific gene Vav1 (Arnt fl/fl Vav-Cre; ARNT conditional knockout) mice, exhibited defective differentiation of iT H 17 cells and enhanced generation of iT reg cells compared to wild-type mice ( Fig. 2a) , similar to results reported for HIF1α-deficient T cells 20 . The defect in the generation of iT H 17 cells also occurred in vivo, as we observed markedly fewer iT H 17 cells in the small intestine lamina propria of ARNT conditional knockout mice ( Fig. 2b) . To our surprise, however, we found more nT H 17 cells in thymi of ARNT conditional knockout mice compared to wild-type controls (Fig. 2c) . Similar to the case in cells from wild-type mice, ARNT-deficient nT H 17 cells also expressed both IL-17F and IL-22 ( Supplementary Fig. 5 ). Thymic nT reg cells were not affected by ARNT deficiency (Fig. 2c) , similar to what has been reported for mice with loxP-flanked Hif1a alleles that also expressed A r t i c l e s retrActed Cre recombinase from the Cd4 gene (Hif1α fl/fl CD4-Cre mice) 19, 20 . ARNT also regulates the activity of aryl hydrocarbon receptor (AhR), which is important in the development of iT H 17 cells 22, 23 . In contrast to the selectively high expression of AhR in iT H 17 cells, expression of AhR in nT H 17 cells was lower, similar to that in mature naive CD4 + T cells and other thymocyte populations ( Fig. 2d) . Thus, it appears likely that nT H 17 cells develop independently of AhR.
Our finding that ARNT has different roles in the development of nT H 17 versus iT H 17 cells led us to investigate the role of mTORC1 in the development of nT H 17 cells. mTORC1 is regulated by a small GTPase Rheb, which is activated after phosphorylation and inhibition of the GTPase-activating protein TSC, which is composed of TSC1 and TSC2. Deletion of Rheb in T cells abrogates activation of mTORC1 (ref. 13) . Consistent with the defective iT H 17 cell differentiation previously reported in Rheb-deficient T cells 13 , we found that the frequency of iT H 17 cells was lower in the small intestinal lamina propria of mice with loxP-flanked Rheb alleles that also expressed the Cd4-cre transgene (Rheb fl/fl CD4-Cre, here called Rheb ∆T ) mice ( Fig. 2e) . In contrast, nT H 17 cell numbers were not decreased in the thymi of Rheb ∆T mice ( Fig. 2f) . Taken together, these results show that the mTORC1-ARNT-HIF1α pathway, although critical for the development of iT H and Foxp3 in thymocytes from day 7 of embryonic day 15(E15)-initiated fetal thymic organ culture (FTOC), cultured for the last 2 d in the presence of indicated concentrations of AKTi, and stimulated with PMA and ionomycin before staining. Flow cytometry plots were gated on CD4 + CD8 − TCRβ + TCRγδ − cells (left). Percentages of IL-17A + or Foxp3 + cells among CD4 + CD8 − thymocytes are graphed (*P < 0.0001, **P = 0.0124; two-tailed Student's t-test). (f) Flow cytometry analysis of IL-17 production in thymocytes from wild-type (WT) and myr-Akt mice after ex vivo stimulation, gated on CD4 + CD8 − TCRβ + TCRγδ − (CD4SP) cells (*P = 0.013, two-tailed Student's t-test). (g) Flow cytometry analysis of wild-type naive (CD44 lo CD62L hi CD25 -) CD4 + T cells activated for 18 h with anti-CD3 plus anti-CD28, followed by 36 h of culture in iT H 17-polarizing conditions in the presence of indicated concentrations of AKTi. IL-17 or Foxp3 expression was determined after restimulation with PMA and ionomycin (*P ≤ 0.05, **P ≤ 0.001, one-way ANOVA followed by Dunnett's post-hoc test with '0 µM' as control group). Numbers in plots indicate percent gated cells (mean ± s.e.m. in c). Flow cytometry plots are representative of three independent experiments (a-d,g) or two independent experiments (e,f) with n ≥ 3 total mice (error bars, ± s.e.m.; e-g). Graphs show cumulative data (e-g).
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VOLUME 14 NUMBER 6 JUNE 2013 nature immunology A r t i c l e s retrActed we used mice with deletion of Rictor selectively in the T cell compartment (mice with loxP-flanked Rictor alleles that also expressed the Cd4-cre transgene (Rictor fl/fl CD4-Cre), here called Rictor ∆T mice). Analysis of thymi from these mice revealed greatly defective development of nT H 17 cells (Fig. 3a) . In contrast, in vivo generation of iT H 17 cells remained intact in Rictor ∆T mice as we found small intestinal lamina propria iT H 17 cells at frequencies similar to those in wildtype mice (Fig. 3b) , consistent with the ability of Rictor-deficient T cells to differentiate into iT H 17 cells in vitro 13 . Collectively, these data indicate that although Akt is critical for development of both nT H 17 and iT H 17 cells, these two subsets of cells have opposing reliance on the functions of mTORC1 versus mTORC2. T cells and thymocytes 19, 24 . Given the requirement of both mTORC2 and Akt for development of nT H 17 cells, we investigated the role of Foxo proteins in the development of these cells. As phosphorylation of Foxo proteins leads to their degradation, we hypothesized that Foxo proteins might be negative regulators of nT H 17 cell development and that Foxo function might be lower in nT H 17 cells compared to other thymocyte populations. We tested this first by examining mRNA abundance of two transcriptional targets of Foxo, Klf2 and S1pr1.
Using RT-PCR, we found that mRNA expression of both genes was diminished in nT H 17 cells compared to CD44 lo CCR6 − CD4 + CD8 − thymocytes (Fig. 4a) . As expected, because Foxo proteins bind to the Foxp3 locus and positively control Foxp3 + T reg cell differentiation 25, 26 , Klf2 and S1pr1 mRNA expression was greater in nT reg cells compared to CD4 + CD8 − thymocytes (Fig. 4a) . To directly test the function of Foxo proteins in development of nT H 17 cells, we used mice with both Foxo1 and Foxo3a deleted in T cells (mice with Foxo1 and Foxo3a alleles flanked by loxP sites that also express the Cd4-cre transgene (Foxo1 fl/fl Foxo3a fl/fl CD4-Cre), referred to as Foxo1 ∆T Foxo3 ∆T mice). As these mice develop an inflammatory phenotype as they age, we restricted our analysis to 3-week-old mice 25 . Foxo1 ∆T Foxo3 ∆T mice had more nT H 17 cells in the thymus compared to wild-type mice (Fig. 4b) , suggesting that Foxo proteins negatively regulate development of nT H 17 cells. Although it is possible that peripheral cytokine dysregulation could alter the thymic environment, mice used in this study exhibited no overt signs of disease. Moreover, the previously reported defect in development of T reg cells observed in 3-week-old Foxo1 ∆T Foxo3 ∆T mice is cell-autonomous and occurs independently of peripheral T cell activation. Together with the cell-intrinsic downregulation of Foxo targets, these data suggest Foxo proteins restrict development of nT H 17 cells. We also investigated the role of another key Akt substrate, GSK3, which is inhibited upon being phosphorylated by Akt. Using knock-in mice expressing an 'uninhibitable' form of GSK3α/β, GSK3(S21A,S9A) 27 , we observed generation of nT H 17 and iT H 17 cells, suggesting that inhibition of this kinase does not regulate the development of either subset of T H 17 cells (Fig. 4c,d) .
Differentiation iT H 17 cells requires Akt2
An alternate mechanism by which Akt can regulate different signaling pathways is through the involvement of distinct Akt isoforms. There are three Akt isoforms, Akt1, Akt2 and Akt3, and deletion of both Akt1 and Akt2 results in defective development of thymocytes 15, 16 . Although all three isoforms have a high degree of structural similarity, several studies have demonstrated isoform-specific functions 28, 29 . Therefore, we speculated that different Akt isoforms might mediate the selective involvement of downstream pathways in development of nT H 17 and iT H 17 cells. To test this hypothesis, we used mice deficient in either Akt1 or Akt2. As reported previously 15, 16 , global thymic development was intact in these mice, and we found that development of nT H 17 cells also proceeded normally in the absence of either Akt1 or Akt2 (Fig. 5a) . In contrast, there was a unique requirement for Akt isoforms in development of iT H 17 cells. We observed a marked defect (Fig. 5b) . These findings are not due to different or predominant expression of Akt2 mRNA in iT H 17 cells compared to other thymocyte and T helper cell subsets (Supplementary Fig. 6 ).
In addition, expression of Akt1 and Akt2 was similar in resting and activated T cells, and Akt1 and Akt2 contribute equally to the pool of active Akt at both early and late time points after stimulation with anti-CD3 and anti-CD28 (Supplementary Fig. 7) . IL-6 is important for differentiation of iT H 17 cells and likely contributes to activation of Akt in this context. However, expression of IL-6 receptor was equivalent in wild-type, Akt1 −/− and Akt2 −/− CD4 + T cells (Supplementary Fig. 8a,b) , and phosphorylation of Akt after IL-6 stimulation of CD4 + T cells from Akt1 −/− and Akt2 −/− mice was similar, suggesting that IL-6 did not differently activate Akt1 versus Akt2 (Supplementary Fig. 8c,d) . Thus, the ability of CD4 + T cells to mediate early IL-6 signaling events was not governed uniquely by Akt2.
Akt2 cell-intrinsic regulation of iT H 17 cell development
As Akt2 −/− mice have substantial metabolic abnormalities 30 , it was possible that their defective development of iT H 17 cells was a result of the abnormal physiological environment. To address this possibility, we first cultured purified naive CD4 + T cells from wild-type and Akt2 −/− mice under iT H 17 cell differentiation-promoting conditions in vitro. Akt2 −/− T cells exhibited defective differentiation of iT H 17 cells under optimal T H 17 cell differentiation-promoting conditions (Fig. 6a) . This result was not due to a global defect in A r t i c l e s retrActed differentiation of T helper cells, as differentiation of T H 1 and T H 2 cells was unaffected ( Supplementary Fig. 9a,b) . Moreover, T cells from mice with loxP-flanked Akt2 alleles that also expressed a Cd4-Cre transgene (Akt2 fl/fl CD4-Cre; here called Akt2 ∆T ) exhibited similar defects in differentiation of iT H 17 cells in vitro ( Supplementary  Fig. 9c ). Furthermore, differentiation of iT reg cells from Akt2 −/− T cells was enhanced compared to that of wild-type T cells when cultured under T reg differentiation conditions (Fig. 6b) . In light of our data and previous reports 13, 19, 20 indicating the importance of the ARNT-HIF1α-mTORC1 pathway in development of iT H 17 cells, we assessed expression of HIF1α in in vitro-generated iT H 17 cells. We verified detection of intracellular HIF1α protein expression by flow cytometry in experiments using primary T cells from mice deficient in HIF1/2α and isotype-control antibodies (Supplementary Fig. 10a,b) . When cultured under T H 17 cell differentiation conditions, CD4 + T cells from Akt2 ∆T mice expressed less HIF1α compared to their wild-type counterparts (Fig. 6c) . We observed this defect only after T H 17 cell differentiation, as wild-type and Akt2 ∆T cells stimulated in T H 1 cell differentiation conditions similarly upregulated expression of HIF1α (Supplementary Fig. 10b) . These data indicate that Akt2 is required for proper expression of HIF1α during differentiation of T H 17 cells and provide a potential mechanism by which Akt2 regulates development of iT H 17 and iT reg cells.
To investigate the cell-intrinsic versus cell-extrinsic nature of the iT H 17 cell defect in Akt2 −/− mice, we created mixed bone-marrow chimeras where wild-type (Thy1.1 + ) and Akt2 −/− (Thy1.1 − ) bone marrow progenitor cells were mixed at 1:1 ratio and transplanted into lethally irradiated wild-type (CD45.1 + ) hosts. We assessed T cell populations 8 weeks after transplant. In the small intestine lamina propria, there were much fewer iT H 17 cells of Akt2 −/− bone-marrow origin compared to the cells of wild-type bone-marrow origin that had developed in the same host environment (Fig. 6d) . Analysis of the mesenteric lymph nodes also revealed a selective defect in generation of iT H 17 cells from the Akt2-deficient bone marrow cells (Fig. 6e) .
In the intestine of these chimeras, Foxp3 + T reg cells of Akt2 −/− bonemarrow origin were present at greater frequency compared to those derived from the wild-type bone marrow ( Fig. 6f,g) . Thymic nT H 17 cells developed normally regardless of whether they were of wildtype or of Akt2 −/− bone-marrow origin (Fig. 6h) . Therefore, selective Akt2 deficiency led to defective generation of iT H 17 cells in a cellintrinsic manner.
DISCUSSION
Here we showed that signaling through Akt is a shared and critical component for the development of nT H 17 and iT H 17 cells. This finding suggested that regulation of nT H 17 and iT H 17 populations might follow similar rules. However, we found substantial differences in Akt-related signaling requirements for the development of these distinct subsets of cells, as iT H 17 cells require mTORC1 and the ARNT-HIFα pathway, whereas nT H 17 cells do not. Moreover, mTORC2, an upstream activator of Akt, is essential for development of nT H 17 cells yet is dispensable for differentiation of iTh17 cell. Additionally, we found differences in the requirement of Akt isoforms, as differentiation of iT H 17 cells, but not of nT H 17 cells, was dependent on Akt2. mTORC1 and HIF1α are important for differentiation of iT H 17 cells 13, 19, 20, 31 . Thus, we were surprised to find that generation of nT H 17 cells was intact in Rheb ∆T mice and in mice conditionally deficient in ARNT, a critical cofactor for HIF1α that associates with RORγt to drive expression of the Il17a gene 20 . Production of IL-17 in the absence of ARNT indicates that transcription Il17a in nT H 17 versus iT H 17 cells is regulated in a fundamentally different manner, with possible implications for the function of these subsets of cells in vivo. It is intriguing to speculate that ARNT-HIFα-independent production of IL-17 allows nT H 17 cells to serve as a basal and more consistent source of IL-17, one that optimally produces IL-17 regardless of O 2 availability. Whether IL-17 production from nT H 17 cells remains ARNT-HIFαindependent in peripheral tissues is under investigation.
The notion of Il17a gene regulation being cell type-specific is consistent with a previous report showing that the NF-κB family members RelA and RelB are required for development of IL-17-producing γδ T cells and nT H 17 cells yet dispensable for differentiation of iT H 17 cells 32 . Although the dependence of nT H 17 cells on these NF-κB proteins has been suggested to be downstream of lymphotoxin β receptor signaling, PKCθ phosphorylation and nuclear localization of NF-κB has also been shown to be dependent on mTORC2 (ref. 14). Thus, it is possible that activation of NF-κB by mTORC2 contributes to development of nT H 17 cells. We also demonstrated that Foxo proteins negatively regulate development nT H 17 cells. Foxo proteins regulate several cellular responses and are silenced upon phosphorylation by Akt 33 . In many circumstances, Foxo phosphorylation by Akt is dependent on mTORC2-mediated activation of Akt 7, 8, 24 . Given the requirements for mTORC2, Akt and Foxo inhibition for proper development of nT H 17 cells, we speculate an mTORC2-Akt2-Foxo pathway is critical for development of nT H 17 cells. However, Foxo proteins can also be phosphorylated by other kinases, including SGK1 (ref. 34 ). Therefore, it will be important to determine the role of these kinases in development of nT H 17 cells. Although we did not find a role for GSK3 in development of T H 17 cells, a previous report has described enhanced in vitro differentiation of iT H 17 cells from T cells containing GSK3(S21A,S9A) 35 . Whereas the nature of these discrepant results is unclear, the method for induction of iT H 17 cells in that prior report differs from our method. Additionally, preliminary data from our laboratory have shown no difference in small intestine lamina propria iT H 17 cell numbers in mice expressing GSK3(S21A,S9A) compared to wild-type mice. Moreover, another recent report identified GSK3α as an upstream activator of Akt, suggesting additional complexity in how this kinase may impact development of a T cell subset 36 .
In addition to the different reliance on mTOR complexes, we found distinct roles of Akt isoforms in development of nT H 17 and iT H 17 cells. Analysis of Akt2-deficient mice revealed fewer iT H 17 cells in the small intestine lamina propria but normal numbers of nT H 17 cells. Despite metabolic defects of Akt2 −/− mice 30 , we determined the iT H 17 cell phenotype to be cell-intrinsic, as we observed the same defects in mice in which Akt2 was deleted selectively in T cells. Furthermore, in mixed bone-marrow chimeras generated with wild-type and Akt2 −/− bone-marrow cells, only Akt2 −/− mouse-derived T cells had fewer IL-17-producing CD4 + T cells in the lamina propria. This defect in generation of iT H 17 cells observed in Akt2 −/− mice was recapitulated in vitro where the lack of IL-17 + cells correlated with lower expression of HIF1α. This finding is consistent with the role of HIF1α in differentiation of iT H 17 cells 19, 20 and may provide a mechanistic explanation for the phenotype observed in Akt-deficient T cells.
How Akt isoforms differently activate downstream pathways has not been fully resolved. The three Akt isoforms are structurally similar, especially in their kinase domains, and do not exhibit substrate specificity in vitro 37 . It does not appear that the different reliance on Akt isoforms is due to preferential expression of one isoform over another 38 , as our analysis of mRNA expression did not reveal predominant expression of Akt2 in iT H 17 cells. In addition, Akt1 and Akt2 appear to be equivalently expressed and activated in CD4 + T cells upon stimulation with TCR or cytokines. Several reports have shown requirements for specific Akt isoforms. In many of these cases, isoform-specific subcellular compartmentalization appeared to have a role in Akt isoform-specific functions [39] [40] [41] [42] . In fact, in developing B cells where Akt2 has an isoform-specific role in regulating expression of IL-7R and RAG, different subcellular localization of Akt1 and Akt2 has been observed 43 . It remains to be determined whether Akt2 has a distinct subcellular localization pattern in T cells and, if so, whether that is responsible for its isoform-specific function in iT H 17 cells.
Lastly, in this report we also found that nT H 17 cells were present in human fetal thymus and umbilical cord blood, with constitutive phosphorylation of Akt. Human T H 17 cells have been reported to develop from a precursor population, marked by expression of CD161 (ref. 44) . Before differentiation, these CD161 + T cells express CCR6, RORγt and IL-23R, and are thus reminiscent of nT H 17 cells. Therefore, it is likely that this previously defined precursor population contains nT H 17 cells. Additional characterization will be needed to determine the relationship between these two human T H 17 cell populations.
METHODS
Methods and any associated references are available in the online version of the paper.
